Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PENG Life Science Ventures is a private healthcare and life sciences venture firm and financing advisory focused on supporting companies in the life sciences sector. Publicly available sources describe it as an independent, forward-thinking firm involved in capital advisory, mergers and acquisitions, consulting, and venture support rather than as an operating drug-development biotech company. The firm appears to maintain a portfolio of private biotech companies spanning areas such as ophthalmology, oncology, nephrology, neurology, and infectious disease. Based on available information, PENG Life Science Ventures functions primarily as an investment/advisory platform for life science ventures, with senior professionals including George Ng and co-founder William Pedranti. Its public web presence is limited, and detailed portfolio, financial, and operating data are not broadly disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PENG Life Science Ventures.